

After graduating from Chung-Ang University College of Pharmacy in 1979, Suh went to the U.S.
and obtained a Master of Business Administration from the State University of New York at Buffalo and a Ph.D.
in Health Economics from the University of Minnesota.
Since 1994, he had lectured and researched the field of pharmaceutical economy and policy serving as a professor and director of the Rutgers University Ernest Mario School of Pharmacy.
Prior to teaching at the Rutgers University, Suh was involved in the innovative healthcare policy design team proposed by former U.S.
President Bill Clinton during his election process to propose various research and policies related to drug pricing.
Later, as a tenured professor at Rutgers University, Suh taught and researched in the fields of pharmaceutical economics, policy, and clinical trial design while serving as director of the Center for International Pharmaceutical Economics and Policy.
Suh also participated as an advisor for the New Jersey government for making health care policy decisions.
Suh said, "New Jersey, the state where Rutgers University is located, operates many US government and healthcare-related projects, and is a mecca well known by the global pharmaceutical industry.
As research director, I worked with various major pharmaceutical companies that had headquarters near the university such as Johnson & Johnson, MSD, Sanofi, Novartis, BMS, and Pfizer.
While studying at the University of York and the University of Sheffield in the UK for two years, I participated in the decision-making process of the National Institute for Health and Care Excellence (NICE) while conducting joint research on economic evaluation." These various activities had become the ground for his fame in the US as an economic evaluation and policy expert in the field of pharmaceuticals.
Suh was also the one to suggest that Korea needs a new drug pricing system including the introduction of the economic evaluation system.
In the early 1990s, during the days of the Federation of Korean Medical Insurance Societies before the Health Insurance Review and Assessment Service, Suh introduced the economic evaluation to address the need for an objective indicator of a drug's price.
After becoming a tenured professor at Rutgers University, a position that is extremely difficult even for U.S.
citizens to achieve, why did Suh return to teach at a college of pharmacy in Korea, where professors are required to retire at the age of 65?
The biggest reason for Suh's return to Korea after 25 years was his parents.
When his mother passed away from cancer, Suh chose to return to Korea to take care of his lone father.
“When returning to Korea, I received numerous offers from various top universities in Korea.
However, I chose my alma mater, Chung-Ang University.
While serving as the Dean, I carried out various measures to prepare the college for the 6-year Pharmacy Program and for the establishment of a specialized graduate school for pharmacy.
In addition, I invited international economic evaluation and regulatory science experts from the US FDA, Europe EMA, as well as those in the field of Biologics for multiple international conferences and training courses.” During his tenure at Rutgers University, he, along with the dean, created a 6-year curriculum for the College of Pharmacy.
Among the roughly 130 pharmacy colleges in the U.S., only about 10 including Rutgers University implement the 6-year program that is being currently being pursued in Korea.
“While serving as a professor at the College of Pharmacy of Chung-Ang University, I was able to inform people about the current domestic and foreign medical insurance and drug pricing system, the reality of the international pharmaceutical industry, and the U.S.
drug price system.
At the college system level, my experience in running a 6-year pharmacy program at Rutgers was immensely helpful as Korea's pharmacy education tends to follow the education method used in the U.S.." Suh explained.
While industry-related knowledge and skills are essential for entering the pharmaceutical industry or practicing pharmacy after graduation, Suh believes that the 6-year program should focus on strengthening the student's communication and writing skills as those are the most necessary skills for continued self-development.
He believes that he did his role in the development of the pharmaceutical industry and pharmacy education at Chung-Ang University during the last 9 years.
Recently, he was elected by members to serve as a director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for 3 years, an organization that has 20,000 pharmaceutical economy expert members around the world.
Along with foreign economic policy experts, as a director, Suh said he hopes to be able to contribute to the development of Korea’s economic evaluation system and system development to improve patient access to new drugs.
On his plans after retirement in August, Suh said, "Even after retirement, I plan to find a place where I can continue my contributions to the field of pharmaceutical economy and policy using my various research and policy proposal experiences."
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.